CD8A and neoplasm: A greater number of neoAg-specific CD8+ T cells infiltrated the tumor following neoAg-mRNA-LNP vaccination compared to neoAg-DC vaccination, and this effect was further intensified when combined with anti-PD-1 treatment (Fig. 3e).